AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/381du60
via IFTTT